Hirotsu Bio Science has decided to apply measures based on government policies and action plans.
We have received a request from some of the clinics which handle N-NOSE to postpone/ suspend the implementation of the test. (for the details, please directly confirm with clinics).
In our inspection center, for the safety of the employees, it is planned to decrease its activities.
Hirotsu Bio Science will continue to prioritize the prevention of the spread of the new coronavirus infection both inside and outside of the company and ensure the safety of its employees and business partners.
Thank you for your understanding.
TOKYO, JAPAN – March 6, 2026 – HIROTSU Bio Science Inc. announced the establishment of a new U.S. subsidiary, Hirotsu Global Inc., effectively c . . .
2026.03.06FOR IMMEDIATE RELEASE HIROTSU Bio Science Announces Referral of Former Employee to Prosecutors for Violation of the Unfair Competition Preven . . .
2026.02.05A novel, non-invasive approach to detecting micro-distant metastasis in highly lethal pancreatic cancer. TOKYO, JAPAN – January 5, 2026 – HIR . . .
2026.01.05